SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NKTR Drug delivery Company
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
507 31 0 NKTR
Emcee:  david nordic Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
232Merrill is less cynical than you guys: Headcount reduction, cost controls, and tom pope-5/25/2007
231You beat me too it - my quote was going to be, "we are cutting our way to Robohogs-5/23/2007
230"Solidify the Company's Leadership Position in PEGylation and PulmonaryArthur Radley-5/23/2007
229Robin CEO started 1/15/07. NKTR is now developing their internal pipeline. Peg Idavid nordic-5/23/2007
2289:00am ET Webcast Press Release Source: Nektar Therapeutics Nektar Announcesdavid nordic-5/23/2007
227biz.yahoo.com Some news on NKTR..giving the stock a little lift.Arthur Radley-5/21/2007
226MIRCERA approval ML......MS was 70-35% approval before the FDA decision. Approvadavid nordic-5/21/2007
225NKTR is tied to Roche's Mircera 4% royalty which is not shared by Enzon. Pendavid nordic-5/21/2007
224I agree, wrong call on the reaction by Amgen shares by david, but also wrong caltuck-5/21/2007
223Uhh......it was up 1.5% AH - wrong thread by the way. JonRobohogs-5/19/2007
222Mircera approval based on labeling. Next hurdle is patent case. What make mircedavid nordic-5/18/2007
221The Complex Biosystems CEO's stint was at Affymax Research Institute. Not stuck-5/15/2007
220ENZON is delivering new peg products starting with PFE's irinotecan. Shearwadavid nordic-5/15/2007
219>>Why do I smell 12.50 for next Friday?<< Acute dysosmia is my guestuck-5/15/2007
218Aw, shucks . . . here's an interesting new PEGging technology from Germtuck-5/15/2007
217Why do I smell 12.50 for next Friday? No position here but good luck! JonRobohogs-5/10/2007
216Notable calls with color on Cowen's Ian Sanderson's comments: notablecatuck-5/10/2007
215>>Nektar Therapeutics Announces First Quarter 2007 Results Wednesday May 9tuck-5/9/2007
214Wasn't aware of this program or this disease. Obviously, I need to do more Ian@SI-5/9/2007
213p.s. You do a heck of a job tracking developments throughout the biotech arena. DewDiligence_on_SI-4/13/2007
212<i>Maybe the narrowing of the claims is a measure to cut legal costs ;>DewDiligence_on_SI-4/13/2007
211You're asking me? NVO bought the rights to this stuff by buying up Aradigm&tuck-4/13/2007
210Why waste a lot of money on lawyers if inhaled insulin isn’t selling?DewDiligence_on_SI-4/13/2007
209Exubera patent fight news >>Novo Nordisk scales back patent suit against Ptuck-4/13/2007
208NKTR makes some promotions, new hires, reorganizes, and updates pipe a bit: >tuck-4/9/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News